42,808
Participants
Start Date
July 25, 2019
Primary Completion Date
March 31, 2023
Study Completion Date
June 9, 2025
Stakeholder Survey (Control Period)
Before eSyM go-live, study team members from each site will solicit input via emailed survey, remote meetings and/or in-person meeting on the use of ePROs in oncology from stakeholders to obtain input regarding adaptation, anticipated challenges, and implementation.
Stakeholder Survey (Intervention Period)
After eSyM go-live and on an ongoing basis, we will evaluate the implementation process at each of the sites with a focus on adoption, appropriateness, acceptability, sustainability, penetration, and scalability. We will do so through emailed surveys and/or discussions with health system leadership, clinicians, clinic support staff, and informatics/IT staff.
Qualitative Interview
A small subset of patients and stakeholders were invited to take part in qualitative interviews after the eSyM trial rollout.
SASS Questionnaire
"A subset of control and intervention patients will be asked to complete a research questionnaire called the SASS Questionnaire asking about their Self-efficacy, Attainment of information needs, Symptom burden, and Satisfaction with care."
eSyM
The electronic symptom management (eSyM) program is the EHR-integrated ePRO program being evaluated through this trial.
West Virginia University Medical Center, Morgantown
Baptist Memoiral HealthCare, Memphis
Maine Medical Center, Portland
Dana Farber Cancer Institute, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Brown University Health (formerly Lifespan Cancer Institute), Providence
Collaborators (1)
National Cancer Institute (NCI)
NIH
RTI International
OTHER
Baptist Memorial Health Care Corporation
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
MaineHealth
OTHER
West Virginia University
OTHER
Lifespan
OTHER
Dana-Farber Cancer Institute
OTHER